Fast Forward and EMD Serono announce $1.4M in grants

12/26/2012 | Genetic Engineering & Biotechnology News

ACADIA Pharmaceuticals and the University of California at Los Angeles will receive $545,380; Vicore Pharma, Uppsala University and Charité-Universitätsmedizin Berlin will receive $531,300; and Axxam will receive $402,000 for research on therapies to reverse, treat or prevent nervous system damage due to multiple sclerosis. The grants are through the Accelerating Commercial Development Program funded by the National Multiple Sclerosis Society's Fast Forward subsidiary and Merck KGaA division EMD Serono.

View Full Article in:

Genetic Engineering & Biotechnology News

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Associate Director, Compliance Business Partner I
Boehringer Ingelheim
Ridgefield, CT
Attorney
U.S. DEPARTMENT OF HEALTH & HUMAN SERVICES Food and Drug Administration Office of the Chief Counsel
Silver Spring, MD, MD
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Senior Manager, Clinical Affairs - Advanced Technology
Edwards Lifesciences
Irvine, CA
Director, Litigation & Investigations EMEA
Gilead Sciences
Stockely Park